C. Seidman
Cardiology and Cardiovascular Medicine · 2001–2020
A researcher in the Science corpus: 23 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Cardiology and Cardiovascular Medicine — 174 citations into it
Whom C. Seidman trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- B. Maron (in Cardiology and Cardiovascular Medicine)
Papers from C. Seidman's perspective
Ordered by how strongly the researchers C. Seidman trusts endorse each paper. Same corpus, a different order for every researcher.
- Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. (Journal of the American College of Cardiology)
- Tissue Doppler Imaging Consistently Detects Myocardial Abnormalities in Patients With Hypertrophic Cardiomyopathy and Provides a Novel Means for an Early Diagnosis Before and Independently of… (Circulation)
- Task Force on Sudden Cardiac Death of the European Society of Cardiology. (European Heart Journal)
- Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy (Circulation)
- Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy (Heart)
- Does sports activity enhance the risk of sudden death in adolescents and young adults? (Journal of the American College of Cardiology)
- ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
- The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. (Genome Research)
- Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2 (EMBO Journal)
- A systematic approach to assessing the clinical significance of genetic variants
Their papers
- Cells of the adult human heart (2020) — 1,417 citations
- Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. (2001) — 595 citations
- De novo mutations in histone modifying genes in congenital heart disease (2013) — 900 citations
- Truncations of Titin Causing Dilated Cardiomyopathy (2012) — 1,366 citations
- Sarcomere Protein Gene Mutations in Hypertrophic Cardiomyopathy of the Elderly (2002) — 388 citations
- Dilated Cardiomyopathy and Heart Failure Caused by a Mutation in Phospholamban (2003) — 632 citations
- Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy (2002) — 615 citations
- Fulminant Myocarditis with Combination Immune Checkpoint Blockade (2016) — 1,956 citations
- Shared genetic causes of cardiac hypertrophy in children and adults. (2008) — 406 citations
- Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands (2017) — 773 citations
- SARS-CoV-2 Entry Genes Are Most Highly Expressed in Nasal Goblet and Ciliated Cells within Human Airways (2020) — 2,359 citations
- Macrophages Facilitate Electrical Conduction in the Heart (2017) — 886 citations
- Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity (2015) — 447 citations
- De novo mutations in Congenital Heart Disease with Neurodevelopmental and Other Birth Defects (2015) — 730 citations
- Burden of rare sarcomere gene variants in the Framingham and Jackson Heart Study cohorts. (2012) — 134 citations
- 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines (2011) — 1,435 citations
- 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Soci (2011) — 1,097 citations
- 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines (2011) — 937 citations
- 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2011) — 848 citations
- Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy (2010) — 639 citations